apple tree Partners
Joseph A. Yanchik III, Venture Partner
Joe joined Apple Tree Partners in 2005. He currently is CEO of Aileron Therapeutics, and a Director of Tokai Pharmaceuticals. Joe has fourteen years of experience founding, funding, and developing technology companies. Prior to ATP, he was a member of the senior management team at Mendel Biotechnology, Inc., a private company funded by the Monsanto Company and the Biotechnology Value Fund, which was named by the science journal Acumen one of the 100 most important companies in the world in terms of its impact on human health. Prior to Mendel, he helped found Poetic Genetics, Inc., a gene therapy company based on discoveries out of the Stanford University Medical Center that was subsequently funded by Bill Rutter and his private development enterprise, Synergenics, and he was a founding executive of a CMGI funded Internet company. Joe is a licensed attorney, admitted to practice in New York, California, and the District of Columbia. His legal practice included representing Fortune 500 companies while working at Cahill Gordon & Reindel (NY) and Silicon Valley venture funded start-ups while at Venture Law Group (Menlo Park). He received his J.D. from Villanova University School of Law, at which he was Managing Editor of the Law Review.